• 1
    Department of Health. National suicide prevention strategy for England. London: Department of Health Publications, 2002.
  • 2
    Gunnell D, Frankel S. Prevention of suicide: aspirations and evidence. BMJ 1994; 308: 122733.
  • 3
    Hawton K, Bergen H, Casey D, Simkin S, Palmer B, Cooper J, Kapur N, Horrocks J, House A, Lilley R, Noble R, Owens D. Self-harm in England: a tale of three cities. Multicentre study of self-harm. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 51321.
  • 4
    Wilkinson S, Taylor G, Templeton L, Mistral W, Salter E, Bennett P. Admissions to hospital for deliberate self-harm in England 1995–2000: an analysis of hospital episode statistics. J Public Health Med 2002; 24: 17983.
  • 5
    Kapur N, House A, Creed F, Feldman E, Friedman T, Guthrie E. Management of deliberate self-poisoning in adults in four teaching hospitals: descriptive study. BMJ 1998; 316: 8312.
  • 6
    Hawton K, Harriss L, Zahl D. Deaths from all causes in a long-term follow-up study of 11,583 deliberate self-harm patients. Psychol Med 2006; 36: 397405.
  • 7
    Department of Health. Saving Lives: Our Healthier Nation. London: Department of Health Publications, 1999.
  • 8
    Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm. Systematic review. Br J Psychiatry 2002; 181: 1939.
  • 9
    Rafnsson SB, Oliver JJ, Elton RA, Bateman DN. Poisons admissions in Edinburgh 1981–2001: agent trends and predictors of hospital readmissions. Hum Exp Toxicol 2007; 26: 4957.
  • 10
    Bialas MC, Reid PG, Beck P, Lazarus JH, Smith PM, Scorer RC, Routledge PA. Changing patterns of self-poisoning in a UK health district. QJM 1996; 89: 893901.
  • 11
    McEvedy CJ. Trends in self-poisoning: admissions to a central London hospital, 1991–1994. J R Soc Med 1997; 90: 4968.
  • 12
    Camidge DR, Wood RJ, Bateman DN. The epidemiology of self-poisoning in the UK. Br J Clin Pharmacol 2003; 56: 6139.
  • 13
    Hawton K, Bale L, Casey D, Shepherd A, Simkin S, Harriss L. Monitoring deliberate self-harm presentations to general hospitals. Crisis 2006; 27: 15763.
  • 14
    Leslie S. A survey of admissions following self-poisoning. Psychiatric Bulletin 2005; 29: 3058.
  • 15
    Gunnell D, Bennewith O, Peters TJ, House A, Hawton K. The epidemiology and management of self-harm amongst adults in England. J Public Health (Oxf) 2005; 27: 6773.
  • 16
    Bateman DN, Bain M, Gorman D, Murphy D. Changes in paracetamol, antidepressants and opioid poisoning in Scotland during the 1990s. QJM 2003; 96: 12532.
  • 17
    Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate self-poisoning 1985–1997: trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 22834.
  • 18
    Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, Weitzel H. Paracetamol self-poisoning. Characteristics, prevention and harm reduction. Br J Psychiatry 1996; 168: 438.
  • 19
    Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, Weitzel H. Why patients choose paracetamol for self-poisoning and their knowledge of its dangers. BMJ 1995; 310: 164.
  • 20
    Turvill JL, Burroughs AK, Moore KP. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet 2000; 355: 20489.
  • 21
    Committee on Safety of Medicines; Medicines Control Agency. Paracetamol and aspirin. Current Problems in Pharmacovigilance 1997; 23: 9.
  • 22
    Hawton K, Fagg J, Simkin S, Bale E, Bond A. Trends in deliberate self-harm in Oxford, 1985–1995. Implications for clinical services and the prevention of suicide. Br J Psychiatry 1997; 171: 55660.
  • 23
    Hawkins LC, Edwards JN, Dargan PI. Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature. Drug Saf 2007; 30: 46579.
  • 24
    Prince MI, Thomas SH, James OF, Hudson M. Reduction in incidence of severe paracetamol poisoning. Lancet 2000; 355: 20478.
  • 25
    Gorman DR, Bain M, Inglis JH, Murphy D, Bateman DN. How has legislation restricting paracetamol pack size affected patterns of deprivation related inequalities in self-harm in Scotland? Public Health 2007; 121: 4550.
  • 26
    Hawton K, Townsend E, Deeks J, Appleby L, Gunnell D, Bennewith O, Cooper J. Effects of legislation restricting pack sizes of paracetamol and salicylate on self-poisoning in the United Kingdom: before and after study. BMJ 2001; 322: 12037.
  • 27
    Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, Arundel M, Bernal W, Gunson B, Hudson M, Suri D, Simpson K. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 2004; 329: 1076.
  • 28
    Bateman DN, Gorman DR, Bain M, Inglis JH, House FR, Murphy D. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br J Clin Pharmacol 2006; 62: 57381.
  • 29
    British National Formulary. London: BMJ Publishing Group, 2008.